- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 06.08. | Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why | 1 | Benzinga.com | ||
| 04.08. | Mangoceuticals, Inc.: Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination | 129 | GlobeNewswire (Europe) | Dallas, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") today announced it has received an additional 180-calendar-day extension from... ► Artikel lesen | |
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 03.08. | Nuclea Energy To Go Public Through Mangoceuticals Combination With Former Shareholders Owning About 96% | 2 | pulse2.com | ||
| 30.07. | Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor | 694 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - July 30, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing... ► Artikel lesen | |
| 30.07. | Mangoceuticals agrees to merge with nuclear microreactor developer | 6 | Investing.com | ||
| 30.07. | Mangoceuticals kündigt Fusion mit Nukleartechnik-Unternehmen Nuclea an | 4 | Investing.com Deutsch | ||
| 30.07. | Mangoceuticals, Inc.: Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology | 6.711 | GlobeNewswire (Europe) | Business Combination Agreement to Bring Nuclea's Lead-Cooled Morpheus Microreactor to the Public Markets Amid Surging Power Demand from AI and Data Centers DALLAS, TEXAS, July 30, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 30.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 10.07. | MANGOCEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 02.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.05. | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 01.04. | MANGOCEUTICALS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 31.03. | MANGOCEUTICALS, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 17.03. | Mangoceuticals verklagt Technologie-Dienstleister auf 73 Millionen US-Dollar | 6 | Investing.com Deutsch | ||
| 17.03. | Mangoceuticals, Inc.: Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. | 429 | GlobeNewswire (Europe) | Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals," the "Company," or "MangoRx"), a company focused on developing, marketing, and selling health... ► Artikel lesen | |
| 17.03. | MANGOCEUTICALS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 06.03. | Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds | 386 | GlobeNewswire (Europe) | Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine... ► Artikel lesen | |
| 23.02. | Mangoceuticals: Aktie steigt nach positiven Daten zu antiviralem Geflügel-Wirkstoff | 2 | Investing.com Deutsch | ||
| 23.02. | Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study | 217 | GlobeNewswire (Europe) | Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,485 | +4,53 % | Earnings Call: Healwell AI mit gemischten Q2-2026-Ergebnissen - Aktie gibt nach | ||
| SPINEWAY | 0,113 | -0,53 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| LIFEWARD | 7,380 | -0,51 % | Lifeward Ltd.: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth | Revenue increase and operating performance improve as capital-efficient distribution strategy gains momentum Strengthened balance sheet and expanding rehabilitation platform support continued commercial... ► Artikel lesen | |
| IMUNON | 1,390 | +0,72 % | Imunon outlines OVATION 3 enrollment pace of 0.5 patients per site per month while planning early 2027 OVATION 2 data presentation | ||
| INSPIRE MEDICAL SYSTEMS | 50,000 | -0,99 % | Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan | Generated second quarter revenue of $200.6 millionSecond quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14Second quarter operating cash flow of $23.2 millionAnnounced strategic growth plan... ► Artikel lesen | |
| NUWELLIS, INC | 1,320 | +0,77 % | Nuwellis, Inc. - 8-K, Current Report | ||
| INSPIREMD | 0,655 | -2,96 % | InspireMD Q2 2026 Earnings Preview | ||
| LOGICMARK | - | - | EQS-News: Benzinga: From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster | EQS-News: Benzinga
/ Key word(s): Healthcare
From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster 19.05.2026 / 15:05... ► Artikel lesen | |
| GT BIOPHARMA | 0,296 | -0,07 % | GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2026 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE- in multiple solid tumor types known to express B7-H3... ► Artikel lesen | |
| MYOMO | 1,440 | +13,39 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| INOGEN | 5,100 | 0,00 % | Inogen Inc - 10-Q, Quarterly Report | ||
| INTELLIGENT BIO SOLUTIONS | 2,760 | -0,67 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| GLUCOTRACK | 0,368 | 0,00 % | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| ENVUE MEDICAL | 0,437 | +14,70 % | ENvue Medical, Inc.: ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions | TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into... ► Artikel lesen |
Das Unternehmen MANGOCEUTICALS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,540 Euro und damit +0,02 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.